Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.600
-0.240 (-4.96%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$992,377
Profits / Employee
-$2,640,793
Market Cap
107.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 2 | 33.33% |
| Dec 31, 2022 | 6 | 0 | - |
| Sep 30, 2022 | 6 | 0 | - |
| Jun 30, 2022 | 6 | - | - |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Fortress Biotech | 78 |
| Vivani Medical | 42 |
| Oncolytics Biotech | 29 |
| Cue Biopharma | 29 |
| Black Diamond Therapeutics | 21 |
| Spruce Biosciences | 14 |
| Aldeyra Therapeutics | 7 |
COYA News
- 17 days ago - Coya Therapeutics Slides: Investor presentation - Filings
- 21 days ago - Coya Therapeutics Transcript: AGM 2026 - Transcripts
- 22 days ago - Coya Therapeutics Transcript: Investor update - Transcripts
- 4 weeks ago - Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting - Business Wire
- 4 weeks ago - Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - Business Wire
- 5 weeks ago - Coya Therapeutics initiates first cohort of patients in ALSTARS trial - TheFly
- 5 weeks ago - Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase - Business Wire
- 6 weeks ago - Coya Therapeutics initiated with a Buy at Roth Capital - TheFly